Physician profile
Sandeep G Mistry
NPI 1104039916
$82,415.08
in general payments reported to CMS, 2019-2025
48 companies · $4,589 in 2025
The $4,589 reported for 2025 was more than what 90% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39K · 2020: $8,831 · 2021: $622 · 2022: $2,176 · 2023: $8,343 · 2024: $19K · 2025: $4,589.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $21K · Travel and Lodging: $6,761 · Food and Beverage: $3,808.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $21,000.00 |
| Travel and Lodging | $6,761.49 |
| Food and Beverage | $3,808.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $67,760.79 | 2019-2025 | Davinci Xi |
| Uc-Care (USA), INC | $4,308.46 | 2024 | Navigo Workstation |
| Axonics, INC. | $2,134.89 | 2020-2024 | Axonics |
| Boston Scientific Corporation | $1,394.26 | 2019-2025 | Moses 550 D\F\L, Axonics, Rezum Generator |
| Coloplast Corp | $1,182.88 | 2019-2025 | Titan, Altis, Speedicath |
| Angiodynamics, INC. | $1,074.27 | 2022-2023 | Nanoknife |
| Neotract INC. | $893.77 | 2019 | |
| Edap Technomed INC | $473.98 | 2020-2025 | |
| Abbott Laboratories | $256.01 | 2019-2024 | Octrode |
| Novo Nordisk INC | $248.88 | 2022-2025 | Ozempic, Rivfloza |
| Allergan, INC. | $242.89 | 2019-2022 | |
| Procept Biorobotics Corporation | $230.58 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Valencia Technologies Corporation | $224.39 | 2025 | Ecoin Device Kit |
| 180 Medical, INC. | $204.86 | 2019-2025 | |
| Abbvie INC. | $188.80 | 2022-2025 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $174.29 | 2019-2024 | |
| Olympus America INC. | $147.42 | 2023-2025 | Itind System, Olympus, Soltive |
| Ferring Pharmaceuticals INC. | $110.69 | 2024-2025 | Adstiladrin |
| Amag Pharmaceuticals, INC. | $90.62 | 2019 | |
| Bluewind Medical | $88.90 | 2024 | Revi |
| Urogen Pharma, INC. | $88.86 | 2022-2025 | |
| Agiliti Surgical, INC. | $69.79 | 2025 | Sonablate Hifu, Koelis Trinity Mri/US Fusion |
| Travere Therapeutics, INC. | $66.74 | 2019-2021 | |
| Janssen Biotech, INC. | $59.95 | 2019-2023 | Erleada |
| Verity Pharmaceuticals INC. | $57.28 | 2024-2025 | Trelstar, Tlando |
| Myriad Genetic Laboratories, INC. | $55.50 | 2022-2025 | Prolaris |
| Endo USA, INC. | $49.03 | 2025 | Aveed, Xiaflex |
| Innovation Technologies INC | $47.39 | 2025 | Irrisept |
| Smith+Nephew, INC. | $44.55 | 2021-2022 | |
| Hollister Incorporated | $42.56 | 2021-2024 | Vapro Pocket |
| Ethicon US, LLC | $42.11 | 2022-2025 | Surgicel Nu-Knit, Ethicon |
| Aytu Biopharma, INC. | $36.25 | 2019 | |
| Dendreon Pharmaceuticals LLC | $34.63 | 2022 | |
| Teleflex LLC | $32.76 | 2021 | |
| Endo Pharmaceuticals INC. | $29.68 | 2019-2023 | Aveed, Edex, Xiaflex |
| Mimedx Group, INC. | $27.28 | 2025 | |
| Siemens Medical Solutions USA, INC. | $25.06 | 2024 | Embozene, Varian Cryocare Touch System |
| Telix Pharmaceuticals | $23.43 | 2024 | Illuccix |
| Clarus Therapeutics INC. | $23.34 | 2021 | |
| Calyxo, INC. | $21.92 | 2025 | Cvac Aspiration System |
| Pfizer INC. | $19.55 | 2025 | |
| Myovant Sciences INC. | $19.38 | 2022 | |
| Itamar Medical INC | $18.55 | 2022 | |
| Sumitomo Pharma America, INC. | $18.24 | 2025 | Orgovyx |
| E.R. Squibb & Sons, L.L.C. | $17.29 | 2022 | |
| Therapeuticsmd, INC. | $12.33 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandeep Mistry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.